RxDoctor Payments Data

Haley Kloberdanz

Psychiatric/Mental Health · Johnston, IANPI 1104553304

Payments from drug & device makers

$3,102in general payments, 2019–2025

Across 194 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$765
  • Otsuka America Pharmaceutical, Inc.$393
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$279
  • Johnson & Johnson$229
  • Lundbeck LLC$215
  • Axsome Therapeutics, Inc.$180
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,102100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,102 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$17,280
Medicare patients
17
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$38,866
RexultiBrexpiprazole25$34,507
CaplytaLumateperone Tosylate14$23,839
TrintellixVortioxetine Hydrobromide30$8,725
Clozapine20$2,935
Loreev XrLorazepam22$2,223
Lurasidone Hcl14$1,675
Buspirone Hcl53$1,156
Aripiprazole36$920
Venlafaxine Hcl ErVenlafaxine Hcl68$918
Carbamazepine13$808
Trazodone Hcl66$785
Risperidone17$748
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$681
Lamotrigine93$655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$765$38,86626 claims
Otsuka America Pharmaceutical, Inc.Rexulti$393$34,50725 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$279$23,83914 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$74$8,72530 claims
Almatica Pharma LLCLoreev Xr, Sertraline Hcl$21$2,24643 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Johnston

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →